The research progress of Gd-EOB-DTPA hepatobiliary-specific MRI contrast agent in the imaging diagnosis of small hepatocellular carcinoma
SUN Xia
Abstract：Hepatocellular carcinoma (HCC) is a common primary malignant tumor of the liver in the world, and the morbidity of HCC is increasing year by year. Early diagnosis and timely treatment of HCC is critical to improve the prognosis and survival rate of the patients. Gd-EOB-DTPA is a new hepatocyte-specific contrast agent.It not only has the nature of non-specific extracellular space contrast medium, also can be further specifically taken up by hepatocytes, and it can provide the information of the hepatobiliary phase. The value of Gd-EOB-DTPA enhanced MRI in the diagnosis of HCC is superior to that of conventional extracellular space contrast agent enhanced MRI. We summarized the application status of Gd-EOB-DTPA enhanced MRI in diagnosis and differential diagnosis of small hepatocellular carcinoma.
Keywords：Hepatocelluar carcinomaMagnetic resonance imagingContrast agentGd-EOB-DTPADifferential diagnosis
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 298-303 )